Mifamurtide
Mepact (mifamurtide) is a small molecule pharmaceutical. Mifamurtide was first approved as Mepact on 2009-03-06. It has been approved in Europe to treat osteosarcoma.
| Trade Name | Mepact |
|---|---|
| Common Name | Mifamurtide |
| Indication | osteosarcoma |
| Drug Class | Peptides: peptides with muranic acid present |
